RoundTable Healthcare Partners ("RoundTable") and Dempsey Ventures announced today that they have entered into a definitive agreement to sell Beaver-Visitec International Holdings, Inc. ("BVI" or the "Company") to TPG Capital ("TPG"). TPG is a global private investment firm founded in 1992 with over $70 billion of assets under management. Terms of the transaction were not disclosed. The transaction is expected to close during the third quarter.
BVI, based in Waltham, MA, is a global developer, manufacturer, and marketer of specialized surgical devices for the ophthalmic marketplace. BVI brings together the brands of Beaver® blades, Visitec® cannulae and instruments, Merocel® and Weck-Cel® ophthalmic fluid management products, and Wet-Field Eraser® electrosurgery products. The products serve a wide variety of ophthalmic surgeries, including cataract, refractive, oculoplastic and vitreoretinal sub-specialty procedures. The Company operates two state-of-the-art manufacturing plants in Waltham, MA and Bidford in the United Kingdom. RoundTable formed BVI in 2010 by acquiring and integrating three separate ophthalmic product businesses from Becton Dickinson, Medtronic, and Aspen Surgical, respectively.